Medicine and Dentistry
Human Immunodeficiency Virus
73%
Therapeutic Procedure
50%
Patient
45%
Infection
41%
Chemotherapeutic Agent
41%
Drug
41%
Drug Resistance
27%
Prevalence
22%
Combination Therapy
21%
Antiretroviral Therapy
19%
Human Immunodeficiency Virus 1
17%
Antivirus Agent
17%
Resistance Mutation
16%
Inpatient
14%
Child
14%
Hepatitis C Virus
13%
Assay
12%
Analysis
12%
Hepatitis B
12%
Genotype
12%
Age
12%
Proteinase Inhibitor
12%
Integrase
11%
Proteinase
10%
RNA Directed DNA Polymerase
10%
Hepatitis C
10%
Plasma
9%
Vaccine
9%
Prophylaxis
8%
Highly Active Antiretroviral Therapy
8%
Serum
8%
Tropism
8%
Life
8%
COVID-19
7%
Laboratory
7%
Virus Infection
7%
Ritonavir
7%
Follow up
6%
Omicron Coronavirus Variant
6%
Hepatitis Virus
6%
Hepatitis B Virus
6%
Human Immunodeficiency Virus Infection
6%
Monitoring
6%
Efavirenz
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Immunity
5%
Virus
5%
Screening
5%
Hepatitis
5%
Diagnosis
5%
Public Health
5%
Liver
5%
Protein
5%
Person
5%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus 1
83%
Human Immunodeficiency Virus
52%
Mutation
27%
Drug Resistance
20%
Protease
18%
Prevalence
18%
Virus Load
16%
Hepatitis C Virus
15%
Virus
14%
Genotyping
14%
Protein
12%
CXCR4
10%
Peptide
10%
Sample
10%
Protease Inhibitor
9%
Life
9%
Chemokine Receptor
9%
Dynamics
8%
Time
8%
Heavy Chain
8%
Tropism
8%
Surface Property
8%
Nucleic Acid
7%
Phylogeny
7%
Age
7%
RNA
7%
CCR5
6%
Co-Receptor
6%
Taxonomy
6%
N-Terminus
6%
Reverse Transcriptase
5%
Position
5%
Development
5%
Protein Complexes
5%
Enfuvirtide
5%
Dried Blood Spot
5%
Telomerase Reverse Transcriptase
5%
Natural Killer Cell
5%
Protein Folding
5%
Association
5%
Human Immunodeficiency Virus Type 1 Subtype B
5%
Cassia
5%
TaqMan
5%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Mutation
31%
Human Immunodeficiency Virus
27%
Blood Plasma
19%
Drug Resistance
19%
Viral Load
18%
Virus
14%
Reverse Transcriptase
12%
Genotype
12%
Time
12%
Prevalence
11%
Natural Killer Cell
11%
Cells
10%
CXCR4
9%
Vaccine Efficacy
9%
Phylogeny
9%
Dynamics
8%
Sample
8%
Cytotoxic T-Cell
8%
Immunity
8%
Hepatitis C Virus
8%
HIV Type 1
8%
Monospecific Antibody
8%
Molecular Epidemiology
8%
Peripheral Blood Mononuclear Cell
7%
Viral Disease
7%
Amino Terminal Sequence
7%
Humanized Mouse
6%
T-Helper Cell
6%
Tropism
6%
Gene
6%
Immunity
6%
Development
6%
Viremia
5%
CD4
5%
Association
5%